JNJ

238.23

-0.2%↓

UNH

273.19

-0.82%↓

TMO

539.43

-1.35%↓

ABT

112.32

+1.08%↑

ISRG

495.1

+0.46%↑

JNJ

238.23

-0.2%↓

UNH

273.19

-0.82%↓

TMO

539.43

-1.35%↓

ABT

112.32

+1.08%↑

ISRG

495.1

+0.46%↑

JNJ

238.23

-0.2%↓

UNH

273.19

-0.82%↓

TMO

539.43

-1.35%↓

ABT

112.32

+1.08%↑

ISRG

495.1

+0.46%↑

JNJ

238.23

-0.2%↓

UNH

273.19

-0.82%↓

TMO

539.43

-1.35%↓

ABT

112.32

+1.08%↑

ISRG

495.1

+0.46%↑

JNJ

238.23

-0.2%↓

UNH

273.19

-0.82%↓

TMO

539.43

-1.35%↓

ABT

112.32

+1.08%↑

ISRG

495.1

+0.46%↑

Search

McKesson Corp

Closed

SectorHealthcare

934.03 -2.79

Overview

Share price change

24h

Current

Min

929.13

Max

961.85

Key metrics

By Trading Economics

Income

40M

1.3B

Sales

3B

106B

P/E

Sector Avg

27.781

84.243

Dividend yield

0.32

Profit margin

1.177

Employees

43,000

EBITDA

374M

1.8B

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

-0.16% downside

Dividends

By Dow Jones

Dividend yield

Sector Avg

0.32%

2.28%

Next Earnings

7 May 2026

Next Dividend date

1 Apr 2026

Next Ex Dividend date

2 Mar 2026

Market Stats

By TradingEconomics

Market Cap

13B

119B

Previous open

936.82

Previous close

934.03

News Sentiment

By Acuity

33%

67%

86 / 352 Healthcare

Technical Score

By Trading Central

Confidence

Strong Bearish Evidence

McKesson Corp Chart

Past performance is not a reliable indicator of future results.

Related News

10 Feb 2026, 23:26 UTC

Major Market Movers

Moderna Stock Slips After FDA Refuses Flu Vaccine Review

10 Feb 2026, 22:31 UTC

Earnings

Correction to America Movil 4Q Profit Article

10 Feb 2026, 22:22 UTC

Earnings

America Movil 4Q Profit Jumps on Lower Financial Costs

10 Feb 2026, 23:51 UTC

Market Talk
Earnings

Commonwealth Bank's Margin Management Gives It a Platform -- Market Talk

10 Feb 2026, 23:42 UTC

Market Talk

Gold Rises Amid Fed Rate-Cut Prospects -- Market Talk

10 Feb 2026, 23:40 UTC

Market Talk
Earnings

Commonwealth Bank Bear Says 1H Result Looks Strong -- Market Talk

10 Feb 2026, 23:21 UTC

Market Talk

Ford Says EV Shift Was Driven by Demand Changes -- Market Talk

10 Feb 2026, 23:21 UTC

Market Talk

Global Equities Roundup: Market Talk

10 Feb 2026, 22:17 UTC

Market Talk

Australia's One Nation Now Commands Working Class Vote -- Market Talk

10 Feb 2026, 22:15 UTC

Earnings

Humana Earnings Will Shed More Light on Medicare Prospects -- Barrons.com

10 Feb 2026, 22:10 UTC

Earnings

Intact Financial 4Q Book Value Per Share Was C$107.35 >IFC.T

10 Feb 2026, 22:10 UTC

Earnings

Intact Financial Raises Qtr Dividend to C$1.47 >IFC.T

10 Feb 2026, 22:09 UTC

Earnings

Intact Financial 4Q Combined Ratio Was 85.9% >IFC.T

10 Feb 2026, 22:09 UTC

Earnings

Intact Financial 4Q Adj EPS C$5.50 >IFC.T

10 Feb 2026, 22:01 UTC

Earnings

Intact Financial 4Q EPS C$5.24 >IFC.T

10 Feb 2026, 21:54 UTC

Earnings

James Hardie Industries Sees FY26 Total Adjusted EBITDA $1.232B to $1.263B >JHX

10 Feb 2026, 21:53 UTC

Earnings

Robinhood Stock Tumbles as Crypto-Related Revenue Falls Short of Expectations -- Barrons.com

10 Feb 2026, 21:51 UTC

Earnings

James Hardie Industries Sees FY26 Free Cash Flow at Least $200M

10 Feb 2026, 21:51 UTC

Earnings

Gilead Earnings Surprise. Why The Stock Is Tumbling Anyway. -- Barrons.com

10 Feb 2026, 21:51 UTC

Earnings

James Hardie Industries: Focused on the Achievement of $125 M Target >JHX

10 Feb 2026, 21:51 UTC

Earnings

James Hardie Industries: Integration and Cost Synergies Ahead of Schedule >JHX

10 Feb 2026, 21:51 UTC

Earnings
Acquisitions, Mergers, Takeovers

Evolution Net Debt A$362 Million at Dec. 31 Vs A$1.29 Billion Year Earlier

10 Feb 2026, 21:50 UTC

Earnings
Acquisitions, Mergers, Takeovers

Evolution: Gearing 6% at Dec. 31, From 23% a Year Earlier

10 Feb 2026, 21:50 UTC

Earnings

James Hardie Industries 3Q EPS 12c >JHX

10 Feb 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

10 Feb 2026, 21:50 UTC

Earnings

James Hardie Industries 3Q Adj EPS 24c >JHX

10 Feb 2026, 21:49 UTC

Earnings

James Hardie Industries 3Q Sales $1.24B >JHX

10 Feb 2026, 21:49 UTC

Earnings
Acquisitions, Mergers, Takeovers

Evolution 1H Operating Mine Cash Flow a Record A$1.73 Billion

10 Feb 2026, 21:48 UTC

Earnings
Acquisitions, Mergers, Takeovers

Evolution 1H Ebitda A$1.56 Billion, Up 59% On-Year

10 Feb 2026, 21:47 UTC

Earnings
Acquisitions, Mergers, Takeovers

Evolution 1H Revenue A$2.79 Billion, Up 37% On-Year

Peer Comparison

Price change

McKesson Corp Forecast

Price Target

By TipRanks

-0.16% downside

12 Months Forecast

Average 960.8 USD  -0.16%

High 1,012 USD

Low 885 USD

Based on 10 Wall Street analysts offering 12 month price targets forMcKesson Corp - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

10 ratings

8

Buy

2

Hold

0

Sell

Technical Score

By Trading Central

681.92 / 707.28Support & Resistance

Short Term

Strong Bearish Evidence

Intermediate Term

No Evidence

Long Term

No Evidence

Sentiment

By Acuity

86 / 352 Healthcare

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About McKesson Corp

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners, and patients to address medication challenges for patients by working across healthcare; connects patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. The Medical-Surgical Solutions segment offers medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
help-icon Live chat